Banque Cantonale Vaudoise Dexcom Inc Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Dexcom Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 11,811 shares of DXCM stock, worth $945,352. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,811

Previous 4,378 169.78%

Holding current value

$945,352

Previous $495,000 59.8%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$64.0 - $116.06 $475,712 - $862,673	7,433 Added 169.78%	11,811 $791,000
Q2 2024 Jul 31, 2024	BUY	$110.31 - $140.45 $267,722 - $340,872	2,427 Added 124.4%	4,378 $495,000
Q1 2024 Apr 10, 2024	SELL	$114.22 - $140.1 $329,753 - $404,468	-2,887 Reduced 59.67%	1,951 $270,000
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $480,267 - $789,905	-6,362 Reduced 56.8%	4,838 $601,000
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $210,588 - $337,514	2,447 Added 27.96%	11,200 $1.04 Million
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $51,398 - $59,857	-457 Reduced 4.96%	8,753 $1.12 Million
Q1 2023 Apr 20, 2023	SELL	$104.0 - $122.92 $200,616 - $237,112	-1,929 Reduced 17.32%	9,210 $1.07 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $255,704 - $369,114	3,009 Added 37.01%	11,139 $1.26 Million
Q3 2022 Oct 17, 2022	SELL	$76.35 - $94.18 $8,093 - $9,983	-106 Reduced 1.29%	8,130 $655,000
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $362,182 - $707,905	5,327 Added 183.12%	8,236 $613,000
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $209,516 - $289,955	-2,227 Reduced 43.36%	2,909 $1.49 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $397,272 - $498,066	3,059 Added 147.28%	5,136 $2.76 Million
Q3 2021 Oct 29, 2021	SELL	$106.71 - $143.18 $23,796 - $31,929	-223 Reduced 9.7%	2,077 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $16,197 - $21,586	200 Added 9.52%	2,300 $982,000
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $16,958 - $20,948	200 Added 10.53%	2,100 $755,000
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $62,400 - $83,600	-800 Reduced 29.63%	1,900 $703,000
Q3 2020 Oct 30, 2020	SELL	$95.51 - $112.95 $305,632 - $361,440	-3,200 Reduced 54.24%	2,700 $278,000
Q2 2020 Jul 22, 2020	SELL	$62.68 - $105.34 $300,864 - $505,632	-4,800 Reduced 44.86%	5,900 $2.39 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $200,718 - $317,646	4,200 Added 64.62%	10,700 $2.88 Million
Q4 2019 Feb 10, 2020	BUY	$36.62 - $57.29 $238,029 - $372,385	6,500 New	6,500 $1.42 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Dexcom Inc Transaction History